Literature DB >> 28220028

Perspective on Clinical Application of Biomarkers in AKI.

Chirag R Parikh1,2,3, Sherry G Mansour4,2.   

Abstract

Several biomarkers of renal injury have been identified but the utility of these biomarkers is largely confined to research studies, whereas widespread clinical applicability is limited. This is partly because the use of serum creatinine as the comparator has several limitations and restricts the full interpretation of biomarker performance. To highlight the potential for clinical application of biomarkers, the most pertinent biomarker data are summarized here, using clinically relevant scenarios in which biomarkers could assist with diagnostic and management dilemmas. The paradigms proposed in this review aim to enhance the clinical diagnosis, management, and prognosis of AKI through the combined use of available clinical markers and novel inflammatory, injury, and repair biomarkers.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  acute renal failure; clinical application; injury biomarkers

Mesh：

Substances：

Year:  2017        PMID： 28220028      PMCID： PMC5461806          DOI： 10.1681/ASN.2016101127

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


  79 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Acute kidney injury: defining prerenal azotemia in clinical practice and research.

Authors:  Chirag R Parikh; Steven G Coca
Journal:  Nat Rev Nephrol       Date:  2010-11       Impact factor: 28.314

3.  Urine stability studies for novel biomarkers of acute kidney injury.

Authors:  Chirag R Parikh; Isabel Butrymowicz; Angela Yu; Vernon M Chinchilli; Meyeon Park; Chi-Yuan Hsu; W Brian Reeves; Prasad Devarajan; Paul L Kimmel; Edward D Siew; Kathleen D Liu
Journal:  Am J Kidney Dis       Date:  2013-11-05       Impact factor: 8.860

4.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

5.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors:  Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

Review 6.  Developing a consensus classification system for acute renal failure.

Authors:  John A Kellum; Nathan Levin; Catherine Bouman; Norbert Lameire
Journal:  Curr Opin Crit Care       Date:  2002-12       Impact factor: 3.687

7.  YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation.

Authors:  Jeremy Puthumana; Isaac E Hall; Peter P Reese; Bernd Schröppel; Francis L Weng; Heather Thiessen-Philbrook; Mona D Doshi; Veena Rao; Chun Geun Lee; Jack A Elias; Lloyd G Cantley; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2016-07-22       Impact factor: 10.121

8.  False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.

Authors:  Jennie Lin; Hilda Fernandez; Michael G S Shashaty; Dan Negoianu; Jeffrey M Testani; Jeffrey S Berns; Chirag R Parikh; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-03       Impact factor: 8.237

Review 9.  Treatment of acute renal failure.

Authors:  R A Star
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more
  21 in total

1.  Are Urinary Biomarkers Better Than Acute Kidney Injury Duration for Predicting Readmission?

Authors:  Jeremiah R Brown; Heather Thiessen-Philbrook; Christine A Goodrich; Andrew R Bohm; Shama S Alam; Steven G Coca; Eric McArthur; Amit X Garg; Chirag R Parikh
Journal:  Ann Thorac Surg       Date:  2019-03-14       Impact factor: 4.330

Review 2.  Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine.

Authors:  Dennis G Moledina; Chirag R Parikh
Journal:  Semin Nephrol       Date:  2018-01       Impact factor: 5.299

3.  Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.

Authors:  Veena S Rao; Tariq Ahmad; Meredith A Brisco-Bacik; Joseph V Bonventre; F Perry Wilson; Edward D Siew; G Michael Felker; Kevin K Anstrom; Devin D Mahoney; Bradley A Bart; W H Wilson Tang; Eric J Velazquez; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2019-06-05       Impact factor: 8.790

4.  Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Intensive Care Unit Admission Diagnosis: A Prospective Cohort Study.

Authors:  Goni Katz-Greenberg; Michael Malinchoc; Dennis L Broyles; David Oxman; Seyed M Hamrahian; Omar H Maarouf
Journal:  Kidney360       Date:  2022-07-13

5.  Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With Hepatitis B Cirrhosis and AKI.

Authors:  Zhonghui Duan; Minjie Jiang; Xiaojie Huang; Haixia Liu; Hongwei Yu; Qinghua Meng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

6.  Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality.

Authors:  Alexandra K Lee; Ronit Katz; Vasantha Jotwani; Pranav S Garimella; Walter T Ambrosius; Alfred K Cheung; Lisa H Gren; Javier A Neyra; Henry Punzi; Kalani L Raphael; Michael G Shlipak; Joachim H Ix
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

Review 7.  Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.

Authors:  Christian Nusshag; Markus A Weigand; Martin Zeier; Christian Morath; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-06-28       Impact factor: 5.923

8.  KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.

Authors:  Dan Xu; Pan-Pan Chen; Pei-Qing Zheng; Fan Yin; Qian Cheng; Zhuan-Li Zhou; Hong-Yan Xie; Jing-Yao Li; Jia-Yun Ni; Yan-Zhe Wang; Si-Jia Chen; Li Zhou; Xiao-Xia Wang; Jun Liu; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2020-07-09       Impact factor: 6.150

9.  Association Between the Concentration and Rangeability of Cystatin C and Mortality of COVID-19 Patients With or Without Type 2 Diabetes Mellitus: A Retrospective Analysis.

Authors:  Lei Yang; Dou Xu; Yiqing Tan; Bolin Li; Dan Zhu; Jingbo Wang; Hui Sun; Xinglong Liu; Xiaopu Zheng; Ling Zhu; Zhongyu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

10.  Subclinical acute kidney injury is associated with adverse outcomes in critically ill neonates and children.

Authors:  Fang Fang; Xiaohan Hu; Xiaomei Dai; Sanfeng Wang; Zhenjiang Bai; Jiao Chen; Jian Pan; Xiaozhong Li; Jian Wang; Yanhong Li
Journal:  Crit Care       Date:  2018-10-10       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.